TY - STD TI - Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death 1999–2013 on CDC WONDER Online database, released 2015. Data are from the Multiple Cause of Death Files, 1999–2013, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program: http://wonder.cdc.gov/ucd-icd10.html. Accessed Feb 3 2015. UR - http://wonder.cdc.gov/ucd-icd10.html ID - ref1 ER - TY - JOUR PY - 2009 DA - 2009// TI - Prevalence and most common causes of disability among adults: United States, 2005 JO - MMWR Morb Mortal Wkly Rep. VL - 58 ID - ref2 ER - TY - JOUR AU - Lo, E. H. AU - Dalkara, T. AU - Moskowitz, M. A. PY - 2003 DA - 2003// TI - Mechanisms, challenges and opportunities in stroke JO - Nat Rev Neurosci VL - 4 UR - https://doi.org/10.1038/nrn1106 DO - 10.1038/nrn1106 ID - Lo2003 ER - TY - JOUR AU - Winstein, C. J. AU - Stein, J. AU - Arena, R. AU - Bates, B. AU - Cherney, L. R. AU - Cramer, S. C. AU - Deruyter, F. AU - Eng, J. J. AU - Fisher, B. AU - Harvey, R. L. PY - 2016 DA - 2016// TI - Guidelines for Adult Stroke Rehabilitation and Recovery A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association JO - Stroke VL - 47 UR - https://doi.org/10.1161/STR.0000000000000098 DO - 10.1161/STR.0000000000000098 ID - Winstein2016 ER - TY - JOUR AU - Gladstone, D. J. AU - Black, S. E. AU - Hakim, A. M. PY - 2002 DA - 2002// TI - Toward wisdom from failure—lessons from neuroprotective stroke trials and new therapeutic directions JO - Stroke VL - 33 UR - https://doi.org/10.1161/01.STR.0000025518.34157.51 DO - 10.1161/01.STR.0000025518.34157.51 ID - Gladstone2002 ER - TY - JOUR AU - Brouns, R. AU - Deyn, P. P. PY - 2009 DA - 2009// TI - The complexity of neurobiological processes in acute ischemic stroke JO - Clin Neurol Neurosurg VL - 111 UR - https://doi.org/10.1016/j.clineuro.2009.04.001 DO - 10.1016/j.clineuro.2009.04.001 ID - Brouns2009 ER - TY - JOUR AU - Vivien, D. AU - Gauberti, M. AU - Montagne, A. AU - Defer, G. AU - Touzé, E. PY - 2011 DA - 2011// TI - Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence JO - J Cereb Blood Flow Metab VL - 31 UR - https://doi.org/10.1038/jcbfm.2011.127 DO - 10.1038/jcbfm.2011.127 ID - Vivien2011 ER - TY - JOUR AU - Hennerici, M. G. AU - Kern, R. AU - Szabo, K. PY - 2013 DA - 2013// TI - Non-pharmacological strategies for the treatment of acute ischaemic stroke JO - Lancet Neurol VL - 12 UR - https://doi.org/10.1016/S1474-4422(13)70091-7 DO - 10.1016/S1474-4422(13)70091-7 ID - Hennerici2013 ER - TY - JOUR AU - Zhou, Y. AU - Yang, L. AU - Ma, A. AU - Zhang, X. AU - Li, W. AU - Yang, W. AU - Chen, C. AU - Jin, X. PY - 2012 DA - 2012// TI - Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor alpha JO - Neuropharmacology VL - 63 UR - https://doi.org/10.1016/j.neuropharm.2012.03.008 DO - 10.1016/j.neuropharm.2012.03.008 ID - Zhou2012 ER - TY - JOUR AU - Zhou, H. AU - Yang, W. -. S. AU - Li, Y. AU - Ren, T. AU - Peng, L. AU - Guo, H. AU - Liu, J. -. F. AU - Zhou, Y. AU - Zhao, Y. AU - Yang, L. -. C. AU - Jin, X. PY - 2017 DA - 2017// TI - Oleoylethanolamide attenuates apoptosis by inhibiting the TLR4/NF-kappa B and ERK1/2 signaling pathways in mice with acute ischemic stroke JO - Naunyn-Schmiedebergs Arch Pharmacol VL - 390 UR - https://doi.org/10.1007/s00210-016-1309-4 DO - 10.1007/s00210-016-1309-4 ID - Zhou2017 ER - TY - JOUR AU - Yang, L. -. C. AU - Guo, H. AU - Zhou, H. AU - Suo, D. -. Q. AU - Li, W. -. J. AU - Zhou, Y. AU - Zhao, Y. AU - Yang, W. -. S. AU - Jin, X. PY - 2015 DA - 2015// TI - Chronic oleoylethanolamide treatment improves spatial cognitive deficits through enhancing hippocampal neurogenesis after transient focal cerebral ischemia JO - Biochem Pharmacol VL - 94 UR - https://doi.org/10.1016/j.bcp.2015.02.012 DO - 10.1016/j.bcp.2015.02.012 ID - Yang2015 ER - TY - JOUR AU - Pialat, J. B. AU - Cho, T. H. AU - Beuf, O. AU - Joye, E. AU - Moucharaffie, S. AU - Langlois, J. B. AU - Nemoz, C. AU - Janier, M. AU - Berthezene, Y. AU - Nighoghossian, N. PY - 2007 DA - 2007// TI - MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice JO - NMR Biomed VL - 20 UR - https://doi.org/10.1002/nbm.1157 DO - 10.1002/nbm.1157 ID - Pialat2007 ER - TY - JOUR AU - Cheng, G. AU - Zhang, X. AU - Gao, D. K. AU - Jiang, X. F. AU - Dong, W. P. PY - 2009 DA - 2009// TI - Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model JO - Neurosci Lett VL - 451 UR - https://doi.org/10.1016/j.neulet.2008.12.045 DO - 10.1016/j.neulet.2008.12.045 ID - Cheng2009 ER - TY - JOUR AU - Collino, M. AU - Aragno, M. AU - Mastrocola, R. AU - Benetti, E. AU - Gallicchio, M. AU - Dianzani, C. AU - Danni, O. AU - Thiemermann, C. AU - Fantozzi, R. PY - 2006 DA - 2006// TI - Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643 JO - Free Radical Biol Med VL - 41 UR - https://doi.org/10.1016/j.freeradbiomed.2006.04.030 DO - 10.1016/j.freeradbiomed.2006.04.030 ID - Collino2006 ER - TY - JOUR AU - Deplanque, D. AU - Gele, P. AU - Petrault, O. AU - Six, I. AU - Furman, C. AU - Bouly, M. AU - Nion, S. AU - Dupuis, B. AU - Leys, D. AU - Fruchart, J. C. PY - 2003 DA - 2003// TI - Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment JO - J Neurosci VL - 23 UR - https://doi.org/10.1523/JNEUROSCI.23-15-06264.2003 DO - 10.1523/JNEUROSCI.23-15-06264.2003 ID - Deplanque2003 ER - TY - JOUR AU - Guzman, M. AU - Lo Verme, J. AU - Fu, J. AU - Oveisi, F. AU - Blazquez, C. AU - Piomelli, D. PY - 2004 DA - 2004// TI - Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha) JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M404087200 DO - 10.1074/jbc.M404087200 ID - Guzman2004 ER - TY - JOUR AU - Fu, J. AU - Gaetani, S. AU - Oveisi, F. AU - Lo Verme, J. AU - Serrano, A. AU - Fonseca, F. R. AU - Rosengarth, A. AU - Luecke, H. AU - Giacomo, B. AU - Tarzia, G. AU - Piomelli, D. PY - 2003 DA - 2003// TI - Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha JO - Nature VL - 425 UR - https://doi.org/10.1038/nature01921 DO - 10.1038/nature01921 ID - Fu2003 ER - TY - JOUR AU - Wulff-Perez, M. AU - Pavon, F. J. AU - Martin-Rodriguez, A. AU - Vicente, J. AU - Alen, F. AU - Fonseca, F. R. AU - Galvez-Ruiz, M. J. AU - Serrano, A. PY - 2014 DA - 2014// TI - Preparation, characterization and in vivo evaluation of nanoemulsions for the controlled delivery of the antiobesity agent N-oleoylethanolamine JO - Nanomedicine VL - 9 UR - https://doi.org/10.2217/nnm.14.35 DO - 10.2217/nnm.14.35 ID - Wulff-Perez2014 ER - TY - JOUR AU - Stegemann, S. AU - Leveiller, F. AU - Franchi, D. AU - Jong, H. AU - Linden, H. PY - 2007 DA - 2007// TI - When poor solubility becomes an issue: from early stage to proof of concept JO - Eur J Pharm Sci VL - 31 UR - https://doi.org/10.1016/j.ejps.2007.05.110 DO - 10.1016/j.ejps.2007.05.110 ID - Stegemann2007 ER - TY - JOUR AU - Lipinski, C. A. PY - 2000 DA - 2000// TI - Drug-like properties and the causes of poor solubility and poor permeability JO - J Pharmacol Toxicol Methods VL - 44 UR - https://doi.org/10.1016/S1056-8719(00)00107-6 DO - 10.1016/S1056-8719(00)00107-6 ID - Lipinski2000 ER - TY - JOUR AU - Porter, C. J. H. AU - Pouton, C. W. AU - Cuine, J. F. AU - Charman, W. N. PY - 2008 DA - 2008// TI - Enhancing intestinal drug solubilisation using lipid-based delivery systems JO - Adv Drug Deliv Rev VL - 60 UR - https://doi.org/10.1016/j.addr.2007.10.014 DO - 10.1016/j.addr.2007.10.014 ID - Porter2008 ER - TY - JOUR AU - Soppimath, K. S. AU - Aminabhavi, T. M. AU - Kulkarni, A. R. AU - Rudzinski, W. E. PY - 2001 DA - 2001// TI - Biodegradable polymeric nanoparticles as drug delivery devices JO - J Control Release VL - 70 UR - https://doi.org/10.1016/S0168-3659(00)00339-4 DO - 10.1016/S0168-3659(00)00339-4 ID - Soppimath2001 ER - TY - JOUR AU - Panyam, J. AU - Labhasetwar, V. PY - 2003 DA - 2003// TI - Biodegradable nanoparticles for drug and gene delivery to cells and tissue JO - Adv Drug Deliv Rev VL - 55 UR - https://doi.org/10.1016/S0169-409X(02)00228-4 DO - 10.1016/S0169-409X(02)00228-4 ID - Panyam2003 ER - TY - JOUR AU - Davis, M. E. AU - Chen, Z. AU - Shin, D. M. PY - 2008 DA - 2008// TI - Nanoparticle therapeutics: an emerging treatment modality for cancer JO - Nat Rev Drug Discovery VL - 7 UR - https://doi.org/10.1038/nrd2614 DO - 10.1038/nrd2614 ID - Davis2008 ER - TY - JOUR AU - Zhang, L. AU - Gu, F. X. AU - Chan, J. M. AU - Wang, A. Z. AU - Langer, R. S. AU - Farokhzad, O. C. PY - 2008 DA - 2008// TI - Nanoparticles in medicine: therapeutic applications and developments JO - Clin Pharmacol Ther VL - 83 UR - https://doi.org/10.1038/sj.clpt.6100400 DO - 10.1038/sj.clpt.6100400 ID - Zhang2008 ER - TY - JOUR AU - Brannon-Peppas, L. AU - Blanchette, J. O. PY - 2004 DA - 2004// TI - Nanoparticle and targeted systems for cancer therapy JO - Adv Drug Deliv Rev VL - 56 UR - https://doi.org/10.1016/j.addr.2004.02.014 DO - 10.1016/j.addr.2004.02.014 ID - Brannon-Peppas2004 ER - TY - JOUR AU - Kreuter, J. PY - 2014 DA - 2014// TI - Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? JO - Adv Drug Deliv Rev VL - 71 UR - https://doi.org/10.1016/j.addr.2013.08.008 DO - 10.1016/j.addr.2013.08.008 ID - Kreuter2014 ER - TY - JOUR AU - Lee, J. -. Y. AU - Chung, S. -. J. AU - Cho, H. -. J. AU - Kim, D. -. D. PY - 2015 DA - 2015// TI - Phenylboronic acid-decorated chondroitin sulfate a-based theranostic nanoparticles for enhanced tumor targeting and penetration JO - Adv Func Mater VL - 25 UR - https://doi.org/10.1002/adfm.201500680 DO - 10.1002/adfm.201500680 ID - Lee2015 ER - TY - JOUR AU - Brigger, I. AU - Dubernet, C. AU - Couvreur, P. PY - 2002 DA - 2002// TI - Nanoparticles in cancer therapy and diagnosis JO - Adv Drug Deliv Rev VL - 54 UR - https://doi.org/10.1016/S0169-409X(02)00044-3 DO - 10.1016/S0169-409X(02)00044-3 ID - Brigger2002 ER - TY - JOUR AU - Hou, Z. AU - Li, Y. AU - Huang, Y. AU - Zhou, C. AU - Lin, J. AU - Wang, Y. AU - Cui, F. AU - Zhou, S. AU - Jia, M. AU - Ye, S. AU - Zhang, Q. PY - 2013 DA - 2013// TI - Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery JO - Mol Pharm VL - 10 UR - https://doi.org/10.1021/mp300489p DO - 10.1021/mp300489p ID - Hou2013 ER - TY - JOUR AU - Yu, F. AU - Ao, M. T. AU - Zheng, X. AU - Li, N. N. AU - Xia, J. J. AU - Li, Y. AU - Li, D. H. AU - Hou, Z. Q. AU - Qi, Z. Q. AU - Chen, X. D. PY - 2017 DA - 2017// TI - PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency JO - Drug Delivery VL - 24 UR - https://doi.org/10.1080/10717544.2017.1321062 DO - 10.1080/10717544.2017.1321062 ID - Yu2017 ER - TY - JOUR AU - Radler, J. O. AU - Koltover, I. AU - Salditt, T. AU - Safinya, C. R. PY - 1997 DA - 1997// TI - Structure of DNA-cationic liposome complexes: dNA intercalation in multilamellar membranes in distinct interhelical packing regimes JO - Science VL - 275 UR - https://doi.org/10.1126/science.275.5301.810 DO - 10.1126/science.275.5301.810 ID - Radler1997 ER - TY - JOUR AU - Zhang, R. AU - Song, X. AU - Liang, C. AU - Yi, X. AU - Song, G. AU - Chao, Y. AU - Yang, Y. AU - Yang, K. AU - Feng, L. AU - Liu, Z. PY - 2017 DA - 2017// TI - Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer JO - Biomaterials VL - 138 UR - https://doi.org/10.1016/j.biomaterials.2017.05.025 DO - 10.1016/j.biomaterials.2017.05.025 ID - Zhang2017 ER -